Procurement completed for Dicot's phase 1 studies
Uppsala, January 4, 2023. The pharmaceutical company Dicot announces the contracting of reputable Clinical Trial Consultants AB (CTC) for conducting clinical phase 1 studies intended to start in mid-2023. The studies will take place at the contracted company's research clinic in Uppsala.Dicot is developing a new potency drug with the aim to treat erectile dysfunction and premature ejaculation better than existing drugs. The company has earlier announced its intention to start clinical studies with the drug candidate LIB-01 in mid-2023. As an important part of the preparations for